Authors:
SAWAMOTO Y
PRESCOTT R
ZHONG DG
SAENKO EL
MAUSERBUNSCHOTEN E
PEERLINCK K
VANDENBERG M
SCANDELLA D
Citation: Y. Sawamoto et al., DOMINANT C2 DOMAIN EPITOPE SPECIFICITY OF INHIBITOR ANTIBODIES ELICITED BY A HEAT PASTEURIZED PRODUCT, FACTOR-VIII CPS-P, IN PREVIOUSLY TREATED HEMOPHILIA-A PATIENTS WITHOUT INHIBITORS, Thrombosis and haemostasis, 79(1), 1998, pp. 62-68
Citation: C. Wilms et al., EXACT DETERMINATION OF UV-INDUCED CROSS-LINKS IN 16S RIBOSOMAL-RNA IN30S RIBOSOMAL-SUBUNITS (VOL 3, PG 602, 1997), RNA, 3(8), 1997, pp. 945-945
Authors:
MATHUR A
ZHONG DG
SABHARWAL AK
SMITH KJ
BAJAJ SP
Citation: A. Mathur et al., INTERACTION OF FACTOR IXA WITH FACTOR VIIIA - EFFECTS OF PROTEASE DOMAIN CA2-SITE, PROTEOLYSIS IN THE AUTOLYSIS LOOP, PHOSPHOLIPID, AND FACTOR-X( BINDING), The Journal of biological chemistry, 272(37), 1997, pp. 23418-23426
Authors:
MATHUR A
ZHONG DG
SABHARWAL AK
SMITH KJ
BAJAJ SP
Citation: A. Mathur et al., INTERACTION OF FACTOR IXA WITH FACTOR VIIIA - EFFECTS OF PHOSPHOLIPID, FACTOR-X, AND MUTATIONS IN THE CALCIUM-BINDING SITE OF FACTOR IXA PROTEASE DOMAIN, Circulation, 94(8), 1996, pp. 1569-1569
Citation: Dg. Zhong et al., FIRST EPIDERMAL GROWTH FACTOR-LIKE DOMAIN OF HUMAN BLOOD-COAGULATION FACTOR-IX IS REQUIRED FOR ITS ACTIVATION BY FACTOR VIIA TISSUE FACTOR BUT NOT BY FACTOR XIA, Proceedings of the National Academy of Sciences of the United Statesof America, 91(9), 1994, pp. 3574-3578
Citation: Dg. Zhong et Sp. Bajaj, A PCR-BASED METHOD FOR SITE-SPECIFIC DOMAIN REPLACEMENT THAT DOES NOTREQUIRE RESTRICTION RECOGNITION SEQUENCES, BioTechniques, 15(5), 1993, pp. 874
Citation: Dg. Zhong et al., 1ST EPIDERMAL GROWTH FACTOR-LIKE DOMAIN OF HUMAN FACTOR-IX IS REQUIRED FOR ITS ACTIVATION BY FACTOR-VIIA TISSUE FACTOR BUT NOT BY FACTOR-XIA, Thrombosis and haemostasis, 69(6), 1993, pp. 957-957